AEROSOOTHE- triple antibiotic ointment ointment

Aerosoothe by

Drug Labeling and Warnings

Aerosoothe by is a Otc medication manufactured, distributed, or labeled by Aero Healthcare US LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Active Ingredients: In each gram-Neomycin Sulfate-5 mg (equivalent to 3.5 mg Neomycin), Polymixin B Sulfate-5000 I.U., Bacitracin Zinc-400 I.U.

PURPOSE

WARNINGS

KEEP OUT OF REACH OF CHILDREN

KEEP OUT OF REACH OF CHILDREN.

IF INGESTED, CONTACT A POISON CONTROL CENTER RIGHT AWAY.

DIRECTIONS

• CLEAN AFFECTED AREA
• APPPLY A SMALL AMOUNT 1 TO 3 TIMES DAILY
• MAY COVER WITH A STERILE BANDAGE

INACTIVE INGREDIENT

INACTIVE INGREDIENT: WHITE PETROLATUM

Indications & Usage

FIRST AID TO HELP PREVENT INFECTION IN MINOR SCRAPES, CUTS AND BURNS.

AST05USV1

INGREDIENTS AND APPEARANCE

AEROSOOTHE 
triple antibiotic ointment ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 55305-123
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	5000 [iU]  in 1 g
BACITRACIN ZINC (UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I)	BACITRACIN	400 [iU]  in 1 g
NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	5 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
PETROLATUM (UNII: 4T6H12BN9U)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 55305-123-02	25 in 1 BOX	02/01/2016
1	NDC: 55305-123-01	0.9 g in 1 PACKET; Type 0: Not a Combination Product
2	NDC: 55305-123-03	0.5 g in 1 PACKET; Type 0: Not a Combination Product	10/20/2015

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part333B	10/20/2015

Labeler - Aero Healthcare US LLC (008186174)